trending Market Intelligence /marketintelligence/en/news-insights/trending/lqJDSSOrjOZYZJjm9ZbDMA2 content esgSubNav
In This List

Synthorx names chairman

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Synthorx names chairman

Synthorx Inc. named board member Pratik Shah as the company's chairman.

The company also appointed Andrew Powell to the board.

Powell serves as a director on the boards of Landec Corp. and Aclaris Therapeutics Inc. In addition, he acted as senior vice president, general counsel and corporate secretary of CollaGenex Pharmaceuticals, Inc., Cornerstone Therapeutics, ImClone Systems LLC, InterMune, Inc. and Medivation, Inc. He was also vice president, chief international counsel at Baxter International Inc.

La Jolla, Calif.-based Synthorx is a biotechnology company that discovers and develops protein therapeutics.